BONNIE KIDD: Open Payments
NPI 1861067183 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 50 payments from 12 companies in 2025. Trend: 2023 $1,305 · 2024 $1,337 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $210 |
| Teva Pharmaceuticals USA, Inc. | 7 | $137 |
| Supernus Pharmaceuticals, Inc. | 4 | $103 |
| Alkermes, Inc. | 4 | $98 |
| ABBVIE INC. | 5 | $87 |
| Axsome Therapeutics, Inc. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Lundbeck LLC | 2 | $58 |
Products named: INGREZZA, UZEDY, Qelbree, VRAYLAR, ARISTADA, REXULTI, COBENFY, ABILIFY MAINTENA.
Industry payments across TN — which companies pay providers there.
